Assessment and Management of Fatigue in Neuromuscular Disease
- 26 February 2010
- journal article
- review article
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 27 (2) , 145-157
Abstract
Fatigue is a common and potentially debilitating symptom of neuromuscular disease (NMD). Studies show that patients with NMD subjectively report increased levels of fatigue. Laboratory testing has demonstrated that patients with NMD show objective physiological signs of increased fatigue, with both central and peripheral components. To date, no treatment has been proven to be truly effective through evidence-based medicine. Thus, the clinician must use a multimodality approach to treating fatigue in patients with NMD. Management interventions are generally based on a sequential approach including treatment of comorbid factors, with the goal of maximizing physical and psychological functioning. This might include low-intensity exercise training, cognitive therapy, treatment of associated depression, correction of risk factors such as obesity, poor nutrition, and inactivity (deconditioning). Optimizing cardiopulmonary function is also critical and measures such as noninvasive, positive pressure ventilation may reduce fatigue in patients with NMD. Novel medications such as modafinil, a nonamphetamine stimulant, may be a helpful pharmacological treatment. Nutraceutical agents, such as creatine monohydrate, coenzyme Q10 (CoQ10), and α-lipoic acid, may also improve neuromuscular function and reduce fatigue.Keywords
This publication has 98 references indexed in Scilit:
- Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: A multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trialClinical Therapeutics, 2009
- Impact of Biopsychosocial Factors on Chronic Pain in Persons With Myotonic and Facioscapulohumeral Muscular DystrophyAmerican Journal of Hospice and Palliative Medicine®, 2009
- Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRSAmyotrophic Lateral Sclerosis, 2008
- The Importance of Assessing Quality of Life in Patients with Neuromuscular DisordersAmerican Journal of Hospice and Palliative Medicine®, 2007
- Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophyJournal of Neurology, 2007
- Modafinil Reduces Fatigue in Charcot-Marie-Tooth Disease Type 1A: A Case SeriesAmerican Journal of Hospice and Palliative Medicine®, 2006
- The Selling of PainAmerican Journal of Physical Medicine & Rehabilitation, 1995
- The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueJournal of Psychosomatic Research, 1995
- The Functional Independence Measure: a comparative study of clinician and self ratingsSpinal Cord, 1993